Table 5.
INT (n 64)† | CON (n 65)† | Differences between groups | |||||
---|---|---|---|---|---|---|---|
Mean | sd | Mean | sd | β | 95 % CI | P ‡ | |
Health transition | |||||||
Baseline | 43·7 | 20·6 | 50·4 | 23·2 | |||
Change after 12 months | 22·2 | 32·7 | −0·4 | 28·5 | 21·6 | 10·7, 32·5 | <0·001 |
General health | |||||||
Baseline | 58·4 | 21·4 | 60·6 | 17·9 | |||
Change after 12 months | 8·2 | 16·8 | −1·5 | 12·3 | 9·2 | 3·9, 14·5 | <0·001 |
Physical functioning | |||||||
Baseline | 74·8 | 23·2 | 78·5 | 20·2 | |||
Change after 12 months | 5·0 | 20·8 | 2·9 | 17·0 | 1·5 | −5·1, 8·1 | 0·65 |
Role physical | |||||||
Baseline | 70·0 | 40·6 | 71·8 | 38·8 | |||
Change after 12 months | −7·5 | 36·0 | −3·2 | 46·3 | −4·7 | −19·9, 10·5 | 0·54 |
Role emotional | |||||||
Baseline | 72·5 | 41·4 | 78·5 | 39·2 | |||
Change after 12 months | −2·9 | 43·3 | 7·0 | 41·4 | −9·7 | −25·5, 6·1 | 0·22 |
Social functioning | |||||||
Baseline | 78·5 | 25·3 | 76·9 | 27·0 | |||
Change after 12 months | −3·5 | 32·8 | 4·2 | 23·6 | −7·5 | −17·5, 2·5 | 0·14 |
Bodily pain | |||||||
Baseline | 65·6 | 28·9 | 69·7 | 26·0 | |||
Change after 12 months | −0·2 | 27·3 | −3·5 | 23·5 | 3·9 | −5·0, 12·9 | 0·39 |
Vitality | |||||||
Baseline | 53·0 | 20·1 | 56·4 | 22·8 | |||
Change after 12 months | 4·5 | 22·4 | −1·0 | 17·3 | 5·0 | −2·0, 12·1 | 0·16 |
Mental health | |||||||
Baseline | 66·7 | 18·4 | 66·6 | 17·6 | |||
Change after 12 months | 2·6 | 17·1 | 0·4 | 17·5 | 2·1 | −4·0, 8·1 | 0·50 |
INT, intervention group; CON, control group.
Data are expressed as mean and sd; or β and 95 % CI.
Health transition: INT n 63, CON n 65; general health: INT n 62, CON n 63; physical functioning: INT n 61, CON n 65; role physical: INT n 60, CON n 62; role emotional: INT n 57, CON n 62; bodily pain: INT n 63, CON n 65; vitality: INT n 62, CON n 65; mental health: INT n 62, CON n 65.
P value for difference between treatment groups in ANCOVA test, adjusted for ethnicity and individuals’ mean value of the measurements at baseline and 12 months for the respective variable.